Arkolith/Insider Trading/MIRM/Form 4

Bjerkholt Eric

CHIEF FINANCIAL OFFICERMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$611K
Net Open-Market Flow
-$611K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 6, 2026Sell(S)3K$121.67$380K44K
Jul 6, 2026Sell(S)1K$122.43$128K43K
Jul 6, 2026Sell(S)528$123.84$65K42K
Jul 6, 2026Sell(S)300$124.94$37K42K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001197350-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML